Active ingredient prescribing
01 Feb 2021
Prescribing medication by its active ingredient will become mandatory from 1 February 2021. The active ingredient must be listed first and can be followed by the brand name if the prescriber believes it is clinically necessary.
The goal of this legislation is to help people understand what medicines they are taking, reducing the risk of accidental multiple doses, and to increase the uptake of generic medicines, thereby reducing cost to patients and the PBS.
Exceptions include:
- handwritten prescriptions
- paper based medication charts in the residential aged care sector
- medicinal items with four or more active ingredients
- other items excluded for safety or practicality reasons.
Prescribing software will require an update and may have some changes to workflows.
Explaining this change to patients will help prevent confusion, especially for those on long-term or multiple medications.
A transition period, until 31 July 2021, will allow pharmacies who receive a non-compliant prescription to request the prescriber to reissue it. If reissue is not possible, the pharmacist may still supply and claim for the medicine under the PBS or RPBS. From 1 August 2021, new prescriptions that do not meet active ingredient prescribing requirements cannot be dispensed as PBS prescriptions and will need to be reissued, or dispensed as private prescriptions.
Further information is available from:
- NPS Medicine Wise
- Department of Health
- PBS
- Your software provider
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Doctors Let's Talk: Get Yourself A Fricking GP
Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.
25 Oct 2022
Systematic efforts to reduce harms due to prescribed opioids – webinar recording
Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme.
14 May 2021
Diplomacy in a hierarchy: tips for approaching a difficult conversation
Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.
05 Oct 2020
